Introduction
Motor neuron disease (MND) represents one ofthe major unsolved problems in neurology. The literature is characterized by numerous speculative theories, mostly derived by analogy with other recognized causes of motor neuron death such as poliomyelitis, or from toxic exposures such as lead poisoning. However, analogous reasoning of this type has not, so far, given insights into MND itself, or resulted in testable hypotheses. It is therefore relevant to consider the extent of established knowledge concerning the disease.
Nomenclature
In most countries other than those with a strong British cultural heritage motor neuron disease is known as amyotrophic lateral sclerosis (ALS) the name that Charcot' used in 1869 to describe the typical pathology. In the United Kingdom the term MND has been preferred, used as a generic term to embrace all forms of acquired degenerative disease ofthe motor system, in which both upper and lower motor signs may be present. This is shown in Table  I . Confusion in terminology often implies lack of understanding both of clinical definition and pathogenesis, and this is certainly so in MND. Most patients with MND show the clinical features of the ALS syndrome, only rare patients presenting with the clinical syndromes of primary lateral sclerosis, or progressive muscular atrophy. In about 10% of patients there is a syndrome of progressive bulbar palsy without other manifestations. However, in the terminal phase of the disease more widespread features are almost invariable.2
The problem of research in MND Because MND is a progressive condition that affects the brain and spinal cord, there is no Fatiguability, cramps and weakness are all symptoms of neurogenic disease that are common in the course of MND and that do not require specific explanation in MND as distinct from their occurrence in other neurogenic disorders. The early neurogenic features, however, are frequently asymmetrical although, even at this time, there are usually abnormalities, such as fasciculation, that are detectable in other muscle groups and that indicate more widespread involvement of the motor system. Two-thirds of patients present with weakness of one limb, and this is slightly more likely to consist of weakness of a leg rather than of an arm. The distribution of initial involvement and the subsequent development of more widespread involvement does not follow any predictable pattern, and the factors leading to the specific affection of certain muscle groups at the onset in any individual case are unknown. There is no evidence that the pattern of use of a group of muscles is relevant to the clinical progression of the disease, although this is an attractive notion. However, electromyogram studies suggest that the disease is widespread from the earliest point of diagnosis, when there is already atrophy of some muscle groups. 4 Other current areas of research There are several strands of ideas underlying current research into MND. These relate to the notion that exogenous excitotoxins may play a role in the process of selective neuronal death that characterizes the disease, that mineral deficiency may be important, that the disease may in some way be related to latent infection with polio virus, that autoimmunity may play a role, and that studies of the molecular pathology of motor neurons in MND will yield insights into the disturbance of molecular biology that must underlie neuronal death in the disease. All these avenues are actively being pursued, but only the latter is directly related to MND itself.
The molecular pathology approach is currently interesting because of the emphasis that has been placed on unravelling the pathology and biochemistry of the characteristic intra-neuronal inclusions found in remaining motor neurons at autopsy. Using antibodies to heat shock proteins it has been shown that these remaining motor neurons contain ubiquitinated blob-like and skeinlike cytoplasmic inclusions.30'3' These inclusions are found also in the proximal axons of the ventral horn grey matter and to a lesser extent in the upper motor neuron. Lewy-like inclusions, that are also found in motor neurons in the disease are associated with ubiquitination of the 15 nm filaments that constitute this inclusion.32 Accumulations of phosphorylated neurofilaments are commonly found in familial MND, but are less characteristic of the sporadic disorder.33 34 Bunina bodies, also found in anterior horn cells, are rarely associated with ubiquitin, and other heat shock proteins, for example the 72 kD heat shock proteins are not associated with ubiquitination.35 The question naturally arises as to the significance of these findings. Unfortunately it is probable that the ubiquitination response is non-specific, representing activation of a common pathway for cytoplasmic degradation of damaged or inactivated cellular proteins, rather than a fundamental part of the cellular pathology of MND. Nonetheless, this ubiquitinated inclusion response in damaged anterior horn cells appears to be a specific and almost diagnostic finding in MND, and as such must represent an important cellular response. It is possible that it is induced by damage to the cytoskeletal framework of the cell, perhaps to abnormalities of the microtubular transport proteins, and much current work is directed to this concept.
One of the major difficulties in trying to bring together the strands of current work on MND is that much of this work is disparate. For example, there has recently been a renewal of interest in the old idea that MND might represent a late complication, or a late sequel to remote infection with poliovirus, either as a latent infection or by some other, undefined mechanism.36 The evidence for this concept is largely epidemiological, and relates to the apparent increase in the incidence of the disease that has been reported from surveys in several countries.37 '38 Extensive studies designed to demonstrate poliovirus antigen or antibody in the tissues of patients with MND have been consistently negative, and it therefore seems difficult to reconcile the epidemiological evidence with the other findings. Resolution ofthese problems awaits more definitive data from the developing molecular biological approaches to the disease.
Conclusions
Understanding of the pathogenesis of MND is currently very much a matter for speculation. The available data do not allow formulation of testable hypotheses, and consist mainly of a number of chance observations. Definition of the disease, however, may be achieved from molecular biology, which is beginning to have an impact on our understanding of the molecular pathology of the neuronal cytoskeleton. The new information strongly suggests that there are relatively specific abnormalities in the cytoskeleton ofmotor neurons in the disease. So far, there is no experimental model of the disease, either occurring naturally or in response to the administration of exogenous toxins. It is possible that further exploration of the neurochemistry of neurotoxic substances may provide an insight into the mechanisms of neuronal death in this late onset neuronal degeneration. Studies of the pathogenesis of cytoplasmic inclusions in this and other degenerative diseases promise to be important in this context.
In many ways MND has been the 'Cinderella' of the degenerative disorders, receiving little attention from researchers involved in disorders with a longer life expectancy such as Parkinson's disease, or muscular dystrophy. In addition there has been little ear-marked funding available to encourage investigators to invest in the study of this disorder. The formation of a world-wide network of patientled groups such as the Motor Neurone Disease Association in the United Kingdom, has done much to remedy this situation and it is profoundly to be hoped that this will result in greater understanding and eventually a means of prevention of this tragic disease.
